US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
KV Pharmaceutical Co. CL A (KV.A)
KV Pharmaceutical Co. CL A (KV.A) ニュース

KV.A

K V Pharma (KV.A)

KV Pharmaceutical Co. CL A

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2013/09/16	23 : 26	PR Newswire (US)	KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	NYSE:KV.A	KV Pharmaceutical Co. CL A
2013/01/24	22 : 00	PR Newswire (US)	Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/12/29	02 : 43	PR Newswire (US)	K-V Pharmaceutical Receives Court Approval of Hologic Settlement	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/12/13	08 : 39	PR Newswire (US)	K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/10	21 : 00	PR Newswire (US)	K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/09	00 : 09	PR Newswire (US)	K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/08	01 : 16	PR Newswire (US)	K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/06	20 : 57	PR Newswire (US)	K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/04	13 : 56	PR Newswire (US)	K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/04	00 : 27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/01	06 : 09	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/27	05 : 27	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/21	05 : 05	PR Newswire (US)	K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/14	05 : 43	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/07	05 : 21	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/04	04 : 35	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/02	22 : 15	PR Newswire (US)	FDA Issues Further Guidance About Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/30	07 : 51	PR Newswire (US)	K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/23	05 : 32	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/21	05 : 19	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/19	05 : 36	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/18	22 : 14	PR Newswire (US)	FDA and CMS Issue Important Updates on Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/08	06 : 12	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/26	05 : 15	PR Newswire (US)	K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	06 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	06 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Sterling

American Express

US Dollar vs Euro

JP Morgan Chase

Bank of America

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約